Press Releases
aTyr Pharma Receives EMA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy
aTyr Pharma, Inc , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases announced that the...
Clinical Trials
LEO Pharma announces positive results from phase 2b clinical study for tralokinumab in atopic dermatitis
LEO Pharma today announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe...
Production & Manufacturing
Cellceutix Provides Update on Developing p53 Drug Candidate Kevetrin as an Oral Anti-Cancer Agent
Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory, and antibiotic applications, is pleased to update shareholders on...
Press Releases
CPhI China to Launch China Pharma Week
CPhI & P-MEC China 2017, hosted by UBM EMEA and China Chamber of Commerce ofMedicines & Health Products Importers& Exporters (CCCMHPIE), and co-organized by...
News
Patheon Named Supply Chain Resiliency Partner Of The Year
Patheon N.V. ,a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that the company was...
Drug Research
Titan Pharmaceuticals Receives Fda Communication On Ropinirole Implant Investigational New Drug Application
Titan Pharmaceuticals, Inc ,a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery platform announced...
Clinical Trials
Inovio Reports New Positive Clinical Data on Vaccine Advances in the Fight Against Emerging Infectious Diseases
Inovio Pharmaceuticals, Inc. announced that Dr. David B. Weiner, Inovio’s co-founder, presented positive clinical data on Inovio’s DNA-based vaccines against MERS (GLS-5300) and Zika...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read